Author: Healio ophthalmology

Aldeyra acquires Helio Vision

Aldeyra Therapeutics has acquired the biotechnology company Helio Vision, according to a press release.The acquisition adds Helio’s ADX-2191, intravitreal methotrexate, a phase 3 product candidate for the treatment of proliferative vitreoretinopathy, t…

To the Editor

Thank you for bringing the topic of practice embezzlement to the forefront in the Ocular Surgery News cover story in the Nov. 25, 2018, issue. We agree that physician involvement in practice management is one key to reducing the risk of this problem. W…